Have a personal or library account? Click to login
Expressions and clinical significance of interleukin-1β and cyclooxygenase-2 in serum and synovia of patients with gouty arthritis Cover

Expressions and clinical significance of interleukin-1β and cyclooxygenase-2 in serum and synovia of patients with gouty arthritis

Open Access
|Feb 2022

References

  1. 1. Wu T, Lv H, Wang F, Wang Y. Characterization of Polyphenols from Lycium ruthenicum Fruit by UPLC-QTOF/MS(E) and Their Antioxidant Activity in Caco-2 Cells. J Agric Food Chem. 2016;64(11):2280-8. DOI: 10.1021/acs.jafc.6b0003510.1021/acs.jafc.6b0003526963650
  2. 2. Cabău G, Crișan TO, Klück V, Popp RA, Joosten LAB. Urate-induced immune programming: Consequences for gouty arthritis and hyperuricemia. Immunol Rev. 2020;294(1):92-105. DOI: 10.1111/imr.1283310.1111/imr.12833706512331853991
  3. 3. Hayes ME, Denton J, Freemont AJ, Mawer EB. Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases. Ann Rheum Dis. 1989;48(9):723-9. DOI: 10.1136/ard.48.9.72310.1136/ard.48.9.72310038632802793
  4. 4. Cleophas MC, Crişan TO, Joosten LA. Factors modulating the inflammatory response in acute gouty arthritis. Curr Opin Rheumatol. 2017;29(2):163-70. DOI: 10.1097/BOR.000000000000036610.1097/BOR.000000000000036627941389
  5. 5. Zhang QB, Zhu D, Wen Z, Yi T, Li Q, Qing YF, et al. High levels of serum uric acid, Cystain C and lipids concentration and their clinical significance in primary gouty Arthritis patients. Curr Opin Rheumatol. 2019;15(2):141-5. DOI: 10.2174/15733971146661807 05095625
  6. 6. Liu Y, Tang H, Liu X, Chen H, Feng N, Zhang J, et al. Frontline Science: Reprogramming COX-2, 5-LOX, and CYP4A-mediated arachidonic acid metabolism in macrophages by salidroside alleviates gouty arthritis. J Leukocyte Biol. 2019;105(1):11-24. DOI: 10.1002/JLB.3HI0518-193R10.1002/JLB.3HI0518-193R30265377
  7. 7. Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, et al. 2015 gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheumatol. 2015;67(10):2557-68. DOI: 10.1002/art.3925410.1002/art.39254456615326352873
  8. 8. Ragab G, Elshahaly M, Bardin T. Gout: An old disease in new perspective-A review. J Adv Res. 2017;8(5):495-511. DOI: 10.1016/j.jare.2017.04.00810.1016/j.jare.2017.04.008551215228748116
  9. 9. Luo Y, Wang L, Peng A, Liu JY. Metabolic profiling of human plasma reveals the activation of 5-lipoxygenase in the acute attack of gouty arthritis. Rheumatology. 2019;58(2):345-51. DOI: 10.1093/rheumatology/key28410.1093/rheumatology/key28430247644
  10. 10. Lin J, Li X, Qi W, Yan Y, Chen K, Xue X, et al. Isofraxidin inhibits interleukin-1β induced inflammatory response in human osteoarthritis chondrocytes. Int Immunopharmacol. 2018;64:238-45. DOI: 10.1016/j. intimp.2018.09.003
  11. 11. Park SM, Min BG, Jung JY, Jegal KH, Lee CW, Kim KY, et al. Combination of Pelargonium sidoides and Coptis chinensis root inhibits nuclear factor kappa B-mediated inflammatory response in vitro and in vivo. BMC Complem Altern Med. 2018;18(1):20. DOI: 10.1186/s12906-018-2088-x10.1186/s12906-018-2088-x577552829351747
  12. 12. Chauhan G, Roy K, Kumar G, Kumari P, Alam S, Kishore K, et al. Distinct influence of COX-1 and COX-2 on neuroinflammatory response and associated cognitive deficits during high altitude hypoxia. Neuro-pharmacology. 2019;146:138-48. DOI: 10.1016/j.neuropharm.2018.11.02610.1016/j.neuropharm.2018.11.02630476507
  13. 13. Gao Y, Zhao H, Li Y. Sauchinone prevents IL-1β-induced inflammatory response in human chondrocytes. J Biochem Mol Toxicol. 2018;32(3):e22033. DOI: 10.1002/jbt.2203310.1002/jbt.2203329356224
  14. 14. Zhang QB, Zhu D, Wen Z, Yi T, Li Q, Qing YF, et al. High levels of serum uric acid, Cystain C and lipids concentration and their clinical significance in primary gouty Arthritis patients. Curr Rheumatol Rev. 2019;15(2):141-5. DOI: 10.2174/15733971146661807 05095625
DOI: https://doi.org/10.2478/rrlm-2021-0037 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 41 - 48
Submitted on: Aug 26, 2021
Accepted on: Oct 22, 2021
Published on: Feb 12, 2022
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Gang Chen, Chenghao Xiang, Li Zou, Li Xu, Zhitao Cheng, Yong Liu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.